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Abstract
Introduction:  Biliary  obstruction  is  usually  caused  by  choledocholithiasis.  However,  in  some  cir-
cumstances,  alternative  or  concurring  unusual  ethiologies  such  as  portal  hypertensive  biliopathy
(PHB) must  be  considered.
Clinical  case:  We  present  the  case  of  a  36-year-old  female  complaining  of  jaundice  and  pruritus.
Liver function  tests  were  compatible  with  biliary  obstruction  and  the  ultrasound  scan  of  the
abdomen showed  dilatation  of  the  intrahepatic  biliary  ducts,  a  dilated  common  bile  duct  (CBD)
and biliary  calculi.  The  computed  tomography  of  the  abdomen  revealed  a  portal  cavernoma
encasing  the  CBD.
Discussion:  Portal  cavernoma,  the  hallmark  of  extrahepatic  portal  venous  obstruction,  can
cause PHB.  When  symptomatic,  chronic  cholestasis  is  present  if  a  dominant  stricture  exists
whereas biliary  pain  and  acute  cholangitis  occur  when  choledocholithiasis  prevails.  Management
must be  individualized  and  usually  includes  endoscopic  therapy  to  address  choledocholithiasis
and shunt  surgery  for  deﬁnitive  treatment.
© 2014  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier  España,  S.L.U.  This  is
an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).PALAVRAS  CHAVE
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Caso  clínico:  Apresentamos  o  caso  de  uma  doente  do  sexo  feminino  com  36  anos  de  idade  com
icterícia e  prurido.  O  estudo  bioquímico  era  compatível  com  icterícia  obstrutiva  e  o  estudo
ecográﬁco  do  abdómen  revelou  dilatac¸ão  das  vias  biliares  intra-hepáticas  e  do  colédoco  associ-
ados a  litíase  biliar.  A  tomograﬁa  computorizada  abdominal  realizada  mostrou  a  existência  um
cavernoma  da  veia  porta  a  envolver  o  colédoco.
Discussão:  O  cavernoma  da  porta,  no  contexto  de  obstruc¸ão  portal  venosa  extra-hepática  pode
complicar-se  com  BHP.  Quando  sintomática  manifesta-se  por  colestase  crónica  caso  exista  uma
estenose dominante  ou  dor  biliar  e/ou  colangite  aguda  quando  predomina  a  litíase.  O  trata-
mento deﬁnitivo  é  individualizado,  incluindo  terapêutica  endoscópica  visando  a  litíase  associada
e uma  derivac¸ão  cirúrgica  venosa  porto-sistémica.
© 2014  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  España,  S.L.U.  Este  é
um artigo  Open  Access  sob  a  licença  de  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
1
J
b
c
u
c
c
n
p
i
o
(
j
t
2
A
m
d
p
i
a
s
a
S
a
p
b
e
m
o
9
8
(
v
Figure  1  Axial  image  by  contrast-enhanced  CT  of  the
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s. Introduction
aundice  is  the  most  frequent  presentation  of  liver  and
iliary  disease  and  the  diagnosis  of  obstructive  jaundice
an  usually  be  established  with  simple  laboratory  tests  and
ltrasonography.1 Choledocholithiasis  is  by  far  the  most
ommon  cause  of  biliary  obstruction  but  other  important
onditions  to  consider  are  biliary  or  extrabiliary  malig-
ancy,  pancreatitis,  non-neoplastic  biliary  strictures  and
arasites.2 However,  as  evidenced  by  our  case  report,  imag-
ng  investigations  may  bring  to  light  an  uncommon  cause
f  biliary  obstruction  such  as  portal  hypertensive  biliopathy
PHB)  that  requires  not  only  the  relief  of  the  obstructive
aundice  but  also  the  diagnosis  of  the  cause  of  portal  hyper-
ension  and  its  management.3
. Clinical case
 36-year-old  woman  presented  to  the  emergency  depart-
ent  due  to  jaundice  that  had  ﬁrst  become  apparent  three
ays  earlier.  She  also  reported  pruritus  for  the  last  week,
ale  stools  and  dark  discoloration  of  the  urine.  While  deny-
ng  any  abdominal  pain,  the  patient  did  complain  of  nausea
nd  vomiting.
At  the  time  of  presentation  the  patient  did  not  recall  any
igniﬁcant  past  medical  history  including  blood  transfusions
nd  was  taking  no  prescription  or  over-the-counter  drugs.
he  also  denied  unprotected  sexual  intercourse.
Physical  examination  was  notable  for  marked  jaundice
nd  scratch  induced  excoriations.  The  gallbladder  was  not
alpable  but  a  nontender  hepatomegaly  extending  2  cm
elow  the  ribcage  was  noted.  The  remaining  of  the  physical
xamination  was  unremarkable.
The  initial  laboratory  test  results  consisted  of  a  nor-
al  complete  blood  count  and  a  normal  prothrombin  time
f  10.2  s  (control  12.0  s).  Total  bilirubin  was  elevated  at
.9  mg/dL  (0.3--1.2  mg/dL)  with  a  conjugated  bilirubin  of
.7  mg/dL.  Alkaline  phosphatase  was  also  raised  at  237  IU/L
35--105  IU/L)  as  was  aspartate  aminotransferase  with  a
alue  of  170  IU/L  (<32  IU/L).
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abdomen  showing  the  portal  cavernoma  encasing  the  common
ile duct  (CBD).
An  ultrasound  scan  of  the  abdomen  was  performed  and
howed  dilatation  of  the  intrahepatic  biliary  ducts  as  well
s  a  dilated  common  bile  duct  measuring  8.5  mm  in  diame-
er  with  at  least  one  biliary  calculus  in  its  lumen.  Gallstones
ere  also  present  and  mild  hepatomegaly  and  splenomegaly
ere  reported.  Due  to  the  concern  of  portal  hypertension
aised  by  the  presence  of  splenomegaly,  a  computed  tomog-
aphy  (CT)  of  the  abdomen  was  ordered  and  revealed  an
xtensive  portosystemic  collateral  circulation  and  a  portal
avernoma  encasing  the  common  bile  duct.
At  this  time  the  patient’s  mother  reported  to  the  attend-
ng  physician  that  her  daughter  had  suffered  from  neonatal
epsis  secondary  to  omphalitis  two  weeks  after  birth  (Fig.  1).
After  appropriate  informed  consent  was  obtained,  an
ndoscopic  retrograde  cholangiopancreatography  (ERCP)
as  performed  to  relieve  the  biliary  obstruction.  The
holangiogram  showed  that  while  the  common  bile  duct  had
 normal  diameter  in  its  distal  half,  the  proximal  portion
Portal  hypertensive  biliopathy  
Figure  2  Cholangiogram  during  ERCP  showing  a  saccular
dilatation  in  the  middle  of  the  CBD  with  subtraction  images
compatible  with  calculi  dilatation  in  its  interior.  The  proximal
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bportion  of  the  CBD  was  also  dilated  while  the  diameter  of  the
distal half  remained  normal.
was  dilated  at  10  mm  and  subtraction  images  compatible
with  calculi  were  present.  In  the  transition  between  these
two  segments  of  the  common  bile  duct  a  saccular  dilation
was  formed  and  also  contained  calculi.  After  sphincterotomy
calculi  removal  was  ensued  requiring  mechanical  lithotripsy
and  a  plastic  stent  was  left  in  the  common  bile  duct  since  it
was  not  possible  to  remove  all  calculi.
In  order  to  investigate  conditions  contributing  for  the
cavernoma’s  development,  a  thrombophilia  screen  was
ordered  and  its  results  were  negative.  Further  anatomic
deﬁnition  was  attained  with  the  help  of  a  magnetic  res-
onance  cholangiography  that  revealed,  in  addition  to  the
persistence  of  calculi  in  the  biliary  ducts,  an  anatomical
variant  with  the  biliary  drainage  of  the  posterior  segments
of  the  right  hepatic  lobe  being  done  to  the  left  hepatic  duct
(Fig.  2).  An  esophagogastroduodenoscopy  was  performed
and  was  unremarkable,  showing  no  signs  of  portal  hyper-
tension  namely  esophageal  varices.
The  patient  had  an  excellent  outcome  after  biliary
stenting  with  total  remission  of  symptoms,  jaundice  and  nor-
malization  of  biochemical  markers  of  cholestasis.  The  case
was  presented  to  a  hepatobiliary  surgeon  and  the  patient  is
currently  waiting  for  portosystemic  shunt  surgery.
3. Discussion
In  this  clinical  report  we  present  the  case  of  a  patient  with
biliary  obstruction  caused  by  PHB  which  in  turn  resulted  from
extrahepatic  portal  venous  obstruction  (EHPVO).
Portal  cavernoma,  also  designated  as  portal  vein  cav-
ernomatous  transformation,  consists  in  the  formation  of
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aricose  collaterals  around  an  occluded  segment  of  the
ortal  vein  and  is  the  hallmark  feature  of  EHPVO.4 This
ompensatory  but  pathological  phenomenon  represents
n  important  cause  of  portal  hypertension,  especially  in
eveloping  countries  where  it  accounts  for  40%  of  portal
ypertension  cases.5 In  most  instances  it  presents  in  chil-
ren  as  major  upper  gastrointestinal  bleeding.6 However,  in
 minority  of  individuals  from  which  our  patient  is  an  exam-
le,  EHPVO  may  only  manifest  itself  in  adulthood  as  a  cause
f  chronic  liver  disease,  PHB  or  an  incidental  ﬁnding.7 The
tiology  of  the  portal  cavernoma  itself  is  only  identiﬁed  in
bout  half  the  cases,  being  omphalitis  and  intra-abdominal
epsis  the  leading  causes  in  the  pediatric  population  while
n  adults  a  wide  array  of  conditions  such  as  thrombophilia,
ntra-abdominal  infection  or  malignancy,  myeloproliferative
isorders  and  cirrhosis  have  been  implicated.7,8 In  this  case
e  believe  that  the  driving  force  for  the  portal  cavernoma
evelopment  was  the  omphalitis  episode  that  occurred  in
he  patient’s  infancy.  Concurring  conditions  such  as  throm-
ophilia,  abdominal  sepsis  or  malignancy  were  excluded  due
o  clinical  observation,  evolution  and  appropriate  laboratory
esting  and  imaging.
PHB,  also  commonly  named  pseudosclerosing  cholangi-
is,  portal  ductopathy  or  simply  portal  biliopathy,  is  used
o  describe  the  abnormalities  observed  in  the  full  extent
f  the  biliary  tract  including  intrahepatic  and  extrahepatic
ile  ducts,  gallbladder  and  cystic  duct  in  patients  with  portal
ypertension.3 This  condition  is  mainly  a  feature  of  EHPVO
here  radiological  evidence  of  PHB  is  present  in  81--100%
f  patients  but  it  can  be  found  in  a  small  proportion  of
ndividuals  with  other  causes  of  portal  hypertension.9
The  pathogenesis  of  PHB  is  based  on  three  mechanisms
hat  may  act  individually  or  simultaneously:  compression  of
he  pliable  common  bile  duct  by  the  collaterals  that  form  the
ortal  cavernoma  and  the  connective  tissue  that  develops
ith  time  and  encases  this  duct;  ischemia  induced  by  portal
hrombosis  and  subsequent  sclerosis  of  the  vessels  that  drain
he  bile  ducts  resulting  in  the  formation  of  biliary  strictures;
nﬂammation  and  deposition  of  connective  tissue  caused  by
acterial  cholangitis.9
Choledocholithiasis  is  a common  feature  of  PHB  and  can
e  present  in  as  much  as  84%  of  patients  even  though  this
igh  value  may  represent  a  selection  bias.10 The  increased
ccurrence  of  biliary  stones  in  PHB  is  likely  justiﬁed  by
hronic  cholestasis  and  changes  in  the  constituents  of  bile
hile  reduced  portal  ﬂow  and  liver  dysfunction  may  also
lay  a  role.11
The  proportion  of  patients  with  EHPVO  that  experience
ymptoms  related  to  PHB  ranges  between  5%  and  38%.12,13
hen  symptoms  do  occur,  the  clinical  presentation  is  usually
ither  one  of  chronic  cholestasis  when  strictures  dominate
r  of  biliary  pain  or  acute  cholangitis  when  choledocholithi-
sis  is  the  main  culprit.3 In  this  case,  while  there  was  no
omplaint  of  signiﬁcant  pain  or  features  of  acute  cholan-
itis,  we  believe  that  the  presentation  was  dominated  by
cute  obstruction  of  a  dominant  stricture  of  the  common
ile  duct  by  a  biliary  stone.  This  view  is  not  only  supported
y  the  radiological  diagnosis  of  choledocholithiasis  but  also
y  the  fast  resolution  of  jaundice  and  cholestasis  following
iliary  stenting.  Individuals  who  do  present  with  symptoms
f  PHB  tend  to  do  so  at  an  older  age  when  compared  with
hildren  presenting  with  upper  gastrointestinal  bleeding  or
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18  
plenomegaly  as  features  of  EHPVO,  and  at  a  mean  age  of
6  years  old,  the  same  age  as  our  patient.14
In  this  case  the  suspicion  of  biliary  obstruction  elicited  by
ppropriate  clinical  signs  and  symptoms,  biochemical  abnor-
alities  and  abdominal  ultrasonography  ﬁndings  justiﬁed
btaining  a  CT  scan  than  in  its  turn  diagnosed  portal  caver-
oma  as  the  cause  of  jaundice  and  associated  biliary  calculi
hich  further  drove  testing  and  therapy.
ERCP  has  been  the  traditional  method  of  investigating
HB  and  was  pivotal  in  the  recognition  of  this  condition.  Sev-
ral  characteristic  ﬁndings  have  been  described  and  include
mooth  strictures  of  variable  lengths,  degrees  and  number,
accular  dilations,  indentations,  dilated  intrahepatic  bile
ucts,  as  well  as  ﬁlling  defects  mainly  in  the  common  bile
uct  that  may  represent  calculi  or  varices.14,15 While  its
iagnostic  use  has  been  hindered  by  the  availability  of  non-
nvasive  and  equally  accurate  alternatives,  ERCP  still  has  a
ajor  role  when  therapy  is  anticipated.
With  magnetic  resonance  it  is  now  possible  to  couple
holangiography  and  portography  thus  allowing  the  evalu-
tion  of  all  components  of  PHB  with  a  single  noninvasive
est.4 Since  several  studies  corroborate  that  magnetic  res-
nance  cholangiography  has  a  similar  sensitivity  to  ERCP  in
his  setting,  it  has  become  the  ﬁrst  line  imaging  test  in  this
ondition.16
Endoscopic  ultrasonography  does  not  yet  have  a  deﬁned
ole  in  PHB  and  its  use  is  limited  to  the  cases  where  other
maging  tests  are  unable  to  give  a  clear  answer,  namely  in  the
ifferential  diagnosis  of  common  bile  duct  stones,  calculi  or
umors.17
Therapy  is  currently  not  recommend  for  asymptomatic
ndividuals  with  normal  liver  function  tests.  However,
atients  presenting  with  symptoms  require  an  integrated
anagement  addressing  not  only  biliary  obstruction  but  also
ortal  hypertension.  Endoscopic  treatment  is  the  therapy
f  choice  when  there  is  choledocholithiasis,  acute  cholangi-
is  or  if  shunt  surgery  is  not  possible.3,18--21 ERCP  is  usually
ffective  in  stone  extraction  and  treatment  of  dominant
trictures.3,14,18 However,  the  relief  of  biliary  obstruction
ith  balloon  dilation  and  stenting  is  only  a  temporary
easure  and  mandates  the  construction  of  a  portosys-
emic  venous  shunt  or  regular  sessions  of  endotherapy  since
tents  tend  to  become  clogged  over  time.14 Increased  risk
f  bleeding  is  also  an  issue  due  to  presence  of  venous
ollaterals.22
Patients  that  have  a  shuntable  vein  should  be  offered
ortosystemic  shunt  surgery  since  this  procedure  effec-
ively  addresses  portal  hypertension  and  may  be  the  only
reatment  needed  for  dominant  biliary  strictures.23--25 Tran-
jugular  intrahepatic  portosystemic  shunt  may  be  a  valid
lternative,  albeit  with  less  supporting  evidence,  and  may
e  considered  in  selected  cases  when  surgery  is  not  feasi-
le  or  is  declined.3 In  some  cases  additional  biliary  bypass
urgery  or  cholecystectomy  may  be  required.
Since  our  patient  exhibited  biliary  stones  in  association
ith  PHB  she  was  initially  managed  endoscopically  with
reat  success  and  is  now  awaiting  shunt  surgery  without  any
ymptoms.  The  need  for  an  effective  management  of  por-
al  hypertension  in  this  patients,  even  when  jaundice  has
esolved,  is  emphasized  by  the  diagnosis  of  secondary  biliary
irrhosis  and  liver  dysfunction  in  patients  with  longstanding
nd  untreated  PHB.16,18
1R.  Cardoso  et  al.
In  summary,  PHB  is  an  uncommon  entity  that  seldom
auses  symptoms.  However,  when  symptomatic,  the  mana-
ement  must  be  tailored  individually  and  should  include
hunt  surgery.  Magnetic  resonance  is  the  imaging  modality
f  choice  and  ERCP  is  very  useful  when  biliary  stones,  acute
holangitis  or  contraindications  for  surgery  are  present.
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